Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative
Year: 2020
Type: article
Source: Value in Health
Institutions: European Medicines Agency, Utrecht University, Zorginstituut Nederland, National Pharmaceutical Council, National Institute for Health and Care Excellence, F. Hoffmann-La Roche AG, University of Maryland, Baltimore, Brigham and Women's Hospital, Harvard University, AbbVie (United States)
Language: English
Subfield: Statistics, Probability and Uncertainty
Field: Decision Sciences
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W3085659227
